European Archives - Page 22 of 1486 - European Medical Journal

Lentigo Maligna Progression Risk Remains Low - EMJ

Lentigo Maligna Shows Low Risk of Progression to Melanoma

English registry data show lentigo maligna has only a 1% risk of progression to invasive melanoma over 10 years.

Air Pollution and Brain Health Study - EMJ

Air Pollution Linked to Poorer Brain Health

Researchers have found that air pollution exposure is associated with lower cognitive performance and signs of vascular brain injury.

Rare Cancer MALDI Imaging Study - EMJ

MALDI Imaging Advances Rare Ampullary Cancer Diagnosis

Researchers found that matrix assisted laser desorption ionisation imaging combined with machine learning may improve diagnosis and prognostic assessment in rare ampullary cancer.

Liver Disease Stigma Scale Validated in ALD Study - EMJ

New Liver Disease Stigma Scale Validated in Study

Researchers validate the Liver Disease Stigma Scale, showing higher stigma in alcohol-associated liver disease compared with non-ALD cases.

Cytomegalovirus Screening and Valacyclovir Use Rises - EMJ

Cytomegalovirus Screening Rises After Valacyclovir Trial

CMV screening and antenatal valacyclovir use increased in France after a pivotal 2020 trial, without a rise in pregnancy termination rates.

Navigating comorbidities and polypharmacy in mHSPC

This video podcast covers the current treatment landscape for mHSPC and covers the burden of comorbidities and polypharmacy. Our experts…

From Avoidance to Tolerance: Interview with Jennifer Koplin

One of the things that most excites me is the possibility that in the next 5–10 years, we might start to see large reductions in the number…

Orforglipron Pill Sustains Weight Loss After Injection Discontinuation

Orforglipron pills could offer a new option for stabilising weight changes after injectable GLP-1 therapy, according to the ATTAIN-MAINTAIN trial.

Onc Now: Expanding Genomics in Cancer Care

Onc Now: Expanding Genomics in Cancer Care

In this episode of Onc Now, we examine how genomics is reshaping cancer care, from risk prediction to treatment decisions and NHS…

US flag against blue sky

US cancer centres inundated for new pancreatic cancer drug

After daraxonrasib’s phase 3 trial results were released, there has reportedly been “a deluge of patient requests”.